Global Equine Chorionic Gonadotropin (eCG) Market Strategic Research Report

Scope of the Report

The global Equine Chorionic Gonadotropin (eCG) market size is predicted to grow from US$ 276 million in 2025 to US$ 385 million in 2032; it is expected to grow at a CAGR of 5.0% from 2026 to 2032.

In 2024, global Equine Chorionic Gonadotropin production reached approximately 31.47 million units, with an average global market price of around US$8.5 per unit. Equine chorionic gonadotropin (eCG), also known as pregnant mare serum gonadotropin (PMSG) or equine luteinizing hormone. Equine chorionic gonadotropin is a gonadotropic hormone produced in the chorion of pregnant mares. It is a glycoprotein hormone secreted by fetal-origin trophoblastic epithelial cells that form the endometrial cups.

Equine Chorionic Gonadotropin (eCG) is a highly active biological hormone widely used in animal reproduction management and livestock production. With the modernization and intensification of global livestock farming, there is increasing demand to improve reproductive efficiency and overall productivity, which has steadily expanded the eCG market. In addition, the growing adoption of research techniques and in vitro fertilization has further promoted the application of eCG in scientific studies and assisted reproductive technologies. In the future, improvements in manufacturing processes and quality control are expected to enhance the stability and safety of eCG products, providing more efficient reproductive management tools for the livestock industry. Moreover, trends such as animal welfare, sustainable farming practices, and biotechnological innovations are likely to drive the development of eCG toward higher purity, greater biological activity, and customized formulations, creating new market opportunities. Overall, the eCG market demonstrates strong growth potential, with expanding application areas and significant room for technological advancement. Its role in optimizing animal reproduction and supporting modern farming practices ensures continued relevance and demand in the evolving livestock industry.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Equine Chorionic Gonadotropin (eCG) market?

What factors are driving Equine Chorionic Gonadotropin (eCG) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Equine Chorionic Gonadotropin (eCG) market opportunities vary by end market size?

How does Equine Chorionic Gonadotropin (eCG) break out by Type, by Application?

This report presents a comprehensive overview of the global Equine Chorionic Gonadotropin (eCG) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• 1000IU/Units
• 5000IU/Units
• Others

Segment by Application

• Pigs
• Cattles
• Sheeps
• Horses
• Other Animals

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Equine Chorionic Gonadotropin (eCG) market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Pigs, Cattles, Sheeps evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact